136 related articles for article (PubMed ID: 2224138)
1. Involvement of the p53 tumor suppressor gene in Ph1-positive and Ph1-negative myeloid leukemia.
Velu T
Blood; 1990 Nov; 76(9):1893-4. PubMed ID: 2224138
[No Abstract] [Full Text] [Related]
2. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
[No Abstract] [Full Text] [Related]
3. [i(17q) appearing in acute phase in Ph1-negative, BCR-negative CML].
Uike N; Yamashita S; Obama K; Takahira H; Nakai H; Inazawa J; Umemura T; Akashi K; Kozuru M
Rinsho Ketsueki; 1992 May; 33(5):694-9. PubMed ID: 1630023
[TBL] [Abstract][Full Text] [Related]
4. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
Chen S
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
[TBL] [Abstract][Full Text] [Related]
6. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
[TBL] [Abstract][Full Text] [Related]
7. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
Inokuchi K; Dan K
J Nippon Med Sch; 2001 Aug; 68(4):292-3. PubMed ID: 11505275
[No Abstract] [Full Text] [Related]
8. Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia.
Robak T; Kasznicki M; Strzelecka B; Bartkowiak J; Debiec-Rychter M
Leuk Lymphoma; 1999 Sep; 35(1-2):193-9. PubMed ID: 10512177
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia.
Verma RS; Chandra P
Leuk Res; 2000 Jul; 24(7):631-5. PubMed ID: 10867140
[No Abstract] [Full Text] [Related]
10. Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph1-positive chronic myelogenous leukemia.
Izumi T; Imagawa S; Hatake K; Miura Y; Ariyama T; Inazawa J; Abe T
Int J Hematol; 1996 Jul; 64(1):73-7. PubMed ID: 8757971
[TBL] [Abstract][Full Text] [Related]
11. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia.
Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Saito M; Miura AB
Cancer Genet Cytogenet; 1996 Jul; 89(2):166-9. PubMed ID: 8697426
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cytogenetic studies of a patient with Philadelphia-negative, BCR-positive chronic myeloid leukemia and t(12;12)(q13;p12).
Zaccaria A; Testoni N; Tassinari A; Celso B; Emanuel BS; Budarf M; Saglio G; Guerrasio A; Barletta C; Peschle C
Genes Chromosomes Cancer; 1990 Mar; 1(4):284-8. PubMed ID: 2278960
[TBL] [Abstract][Full Text] [Related]
14. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
[No Abstract] [Full Text] [Related]
15. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
[TBL] [Abstract][Full Text] [Related]
16. Chronic myelogenous leukemia: an update on the biological findings and therapeutic approaches.
Ferrajoli A; Fizzotti M; Liberati AM; Grignani F
Crit Rev Oncol Hematol; 1996 Apr; 22(3):151-74. PubMed ID: 8793272
[No Abstract] [Full Text] [Related]
17. Karyotype analysis in chronic myelogenous leukemia. A three-year experience at the American University of Beirut Medical Center (AUBMC).
el-Assaad W; al-Oreibi G; Zahed L
J Med Liban; 1998; 46(1):16-9. PubMed ID: 9795517
[TBL] [Abstract][Full Text] [Related]
18. Missing Y chromosome in Ph1-negative chronic myeloid leukemia with bcr rearrangement. Evidence for a bcr-abl recombination on chromosome 22 by in situ hybridization.
Uike N; Inazawa J; Nishigaki H; Takahira H; Katsuno M; Hashimoto M; Kozuru M
Acta Haematol; 1991; 85(1):51-5. PubMed ID: 2011934
[TBL] [Abstract][Full Text] [Related]
19. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biology studies in chronic myeloid leukemia].
Cervantes F
Med Clin (Barc); 1993 Oct; 101(14):538-40. PubMed ID: 8231399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
